Palatin Technologies (PTN) Signs Licensing Agreement with Kwangdong Pharmaceutical for Republic of Korea
Tweet Send to a Friend
Palatin Technologies, Inc. (NYSE: PTN) announced today that it has entered into a collaboration and license agreement with Kwangdong ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
